MG-VAX
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

MG-VAX Trademark

Serial Number: 98375046

MG-VAX is a trademark filed by CHIMIGEN BIOMEDICAL (CHENGDU) CO., LTD. on January 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CHIMIGEN BIOMEDICAL (CHENGDU) CO., LTD. (3 trademarks)

No. 18 Shengwucheng Middle Road
Chengdu, Sichuan 610219 , CN

Entity Type: 99

Trademark Details

Filing Date

January 25, 2024

Registration Date

Not Registered

Published for Opposition

November 26, 2024

Goods & Services

Vaccines; Medical diagnostic preparations in the nature of diagnostic preparations for medical use; Medicines for human purpose, namely, medicines for cancer and virus infection; Disinfectants; Dietetic substances adapted for medical use in the nature of dietetic preparations adapted for medical use; Purifying agents, namely, air purifying preparations; Chemical preparations for veterinary purposes in the nature of chemical reagents for veterinary use; Insecticides; Antisepsis papers in the nature of antiseptic wipes; Medical dressings.

Medical instruments and equipment in the nature of medical instruments for analyzing and identifying viruses or cancer; Medical testing instruments in the nature of medical diagnostic apparatus for testing for viruses; Medical bacteria identification analyzers, namely, medical instruments for analyzing and identifying bacteria; Medical analytical instruments in the nature of medical instruments for analyzing and identifying viruses; Dental equipment and instruments, namely, root canal therapy instruments used to shave the inside of a root canal; Medical radiation equipment in the nature of medical radiation apparatus; Masks, namely, oxygen masks for medical purposes; Artificial surgical grafts in the nature of artificial vascular grafts; Orthopedic articles, namely, orthopedic belts; Suture materials.

Quality assessments in the nature of quality evaluation services for the medical and anesthesia industries; Technical research in the field of pharmaceutical studies; Chemical research; Drug research and development in the nature of pharmaceutical research and development; Clinical trials, namely, scientific research in the nature of conducting clinical trial for others; Medical research; Material testing; Industrial design services; Software as a Service (SaaS) services featuring software for use in database management; Graphic arts design.

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 11, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 11, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2024 NWOS
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 17, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
NEW APPLICATION ENTERED
Jan 25, 2024 NWAP